Trending NewsTrending NewsNASDAQ:IART Integra LifeSciences (IART) Stock Price, News & Analysis $12.68 -3.41 (-21.19%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$12.85 +0.17 (+1.33%) As of 10/2/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Integra LifeSciences Stock (NASDAQ:IART) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Integra LifeSciences alerts:Sign Up Key Stats Today's Range$12.63▼$14.0050-Day Range$12.68▼$19.7652-Week Range$8.70▼$20.49Volume2.69 million shsAverage Volume884,975 shsMarket Capitalization$986.12 millionP/E RatioN/ADividend YieldN/APrice Target$18.86Consensus RatingReduce Company Overview Integra LifeSciences Holdings Corporation (NASDAQ:IART) is a global medical technology company that develops and manufactures products used in neurosurgery, reconstructive surgery, and orthopedic procedures. Its offerings are designed to help physicians treat neurological conditions, traumatic injuries, complex wounds, and other surgical needs. The company’s products include dural repair and regeneration materials, cerebrospinal fluid management systems, surgical instruments, nerve and tendon repair products, and tissue-engineered solutions for wound care and reconstructive surgery. Integra is also known for its artificial-skin and dermal regeneration products, which are used to support the treatment of burns and other serious wounds. Founded in 1989, Integra serves hospitals, surgical centers, and healthcare professionals in the United States and international markets. Its business is organized around technologies and products for neurosurgery and reconstructive and orthopedic surgery, with a focus on improving patient outcomes and supporting tissue repair.AI Generated. May Contain Errors. Read More Integra LifeSciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks76th Percentile Overall ScoreIART MarketRank™: Integra LifeSciences scored higher than 76% of companies evaluated by MarketBeat, and ranked 130th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingReduce Consensus RatingIntegra LifeSciences has received a consensus rating of Reduce. The company's average rating score is 1.88, and is based on no strong buy ratings, 1 buy rating, 5 hold ratings, and 2 sell ratings.Upside PotentialIntegra LifeSciences has a consensus price target of $18.86, representing about 48.7% upside from its current price of $12.68.Amount of Analyst CoverageIntegra LifeSciences has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Integra LifeSciences' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth4.47% Earnings GrowthEarnings for Integra LifeSciences are expected to grow by 4.47% in the coming year, from $2.46 to $2.57 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Integra LifeSciences is -140.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Integra LifeSciences is -140.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioIntegra LifeSciences has a PEG Ratio of 0.83. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioIntegra LifeSciences has a P/B Ratio of 0.95. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Integra LifeSciences' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.10% of the float of Integra LifeSciences has been sold short.Short Interest Ratio / Days to CoverIntegra LifeSciences has a short interest ratio ("days to cover") of 8.26.Change versus previous monthShort interest in Integra LifeSciences has recently decreased by 0.76%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIntegra LifeSciences does not currently pay a dividend.Dividend GrowthIntegra LifeSciences does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.08 News SentimentIntegra LifeSciences has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 24 news articles for Integra LifeSciences this week, compared to 3 articles on an average week.MarketBeat Follows3 people have added Integra LifeSciences to their MarketBeat watchlist in the last 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Integra LifeSciences insiders have not sold or bought any company stock.Percentage Held by Insiders3.84% of the stock of Integra LifeSciences is held by insiders.Percentage Held by Institutions84.78% of the stock of Integra LifeSciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Integra LifeSciences' insider trading history. Receive IART Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Integra LifeSciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IART Stock News HeadlinesIntegra LifeSciences (NASDAQ:IART) Stock Rating Cut to "Hold" at Wall Street Zen2 hours ago | americanbankingnews.comIntegra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART)October 2 at 6:42 PM | prnewswire.comThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. | Reagan Gold Group (Ad)Integra LifeSciences stock tumbles after cutting 2026 outlookOctober 2 at 6:17 PM | au.finance.yahoo.comIntegra LifeSciences plunges 21% on preliminary Q3 resultsOctober 2 at 6:17 PM | seekingalpha.comIntegra LifeSciences Launches $600 Million Senior Secured Term Loan BOctober 2 at 1:17 PM | marketscreener.comMIntegra LifeSciences Cuts FY26 Guidance Following Cincinnati Facility Flooding; Stock Tumbles 11.4%October 2 at 1:17 PM | rttnews.comIntegra Lowers FY26 Forecast Following Cincinnati Flood; Plans $600M Debt RefinanceOctober 2 at 1:17 PM | rttnews.comSee More Headlines IART Stock Analysis - Frequently Asked Questions How have IART shares performed this year? Integra LifeSciences' stock was trading at $12.42 on January 1st, 2026. Since then, IART stock has increased by 2.1% and is now trading at $12.68. How were Integra LifeSciences' earnings last quarter? Integra LifeSciences Holdings Corporation (NASDAQ:IART) posted its quarterly earnings data on Wednesday, July, 29th. The life sciences company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.48 by $0.08. The life sciences company earned $418.76 million during the quarter, compared to the consensus estimate of $417.54 million. Integra LifeSciences had a negative net margin of 0.44% and a positive trailing twelve-month return on equity of 18.30%. Read the conference call transcript. When did Integra LifeSciences' stock split? Shares of Integra LifeSciences split before market open on Tuesday, January 3rd 2017.The 2-1 split was announced on Thursday, December 22nd 2016. The newly issued shares were payable to shareholders after the closing bell on Wednesday, December 21st 2016. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Does Integra LifeSciences have any subsidiaries? Integra LifeSciences subsidiaries include ACell Inc, Rebound Therapeutics, Arkis BioSciences, Codman Neuro, TGX Medical Systems, Derma Sciences, Tekmed Instruments S.p.A, and others. How do I buy shares of Integra LifeSciences? Shares of IART stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Integra LifeSciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Integra LifeSciences investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Netflix (NFLX), JPMorgan Chase & Co. (JPM), Tesla (TSLA) and Home Depot (HD). Company Calendar Last Earnings7/29/2026Today10/02/2026Next Earnings (Estimated)10/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1d) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 IART's financial health is in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:IART CIK917520 Webwww.integralife.com Phone(609) 275-0500Fax609-750-4277Employees4,427Year Founded1989Price Target and Rating Average Price Target for Integra LifeSciences$18.86 High Price Target$25.00 Low Price Target$13.00 Potential Upside/Downside+48.7%Consensus RatingReduce Rating Score (0-4)1.88 Research Coverage8 Analysts Profitability EPS (Trailing Twelve Months)($0.09) Trailing P/E RatioN/A Forward P/E Ratio5.15 P/E Growth0.83Net Income-$516.47 million Net Margins-0.44% Pretax Margin-0.01% Return on Equity18.30% Return on Assets5.30% Debt Debt-to-Equity Ratio1.75 Current Ratio3.60 Quick Ratio2.11 Sales & Book Value Annual Sales$1.64 billion Price / Sales0.60 Cash Flow$3.33 per share Price / Cash Flow3.81 Book Value$13.40 per share Price / Book0.95Miscellaneous Outstanding Shares77,770,000Free Float74,787,000Market Cap$986.12 million OptionableOptionable Beta1.21 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:IART) was last updated on 10/3/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
